Sepracor Xopenex metered-dose inhaler
Executive Summary
Sepracor and 3M Drug Delivery Systems announce collaboration on scale-up and manufacturing of a Xopenex hydrofluoroalkane metered-dose inhaler. Sepracor is conducting large-scale clinical trials of a levalbuterol HFA MDI formulation. The short-acting beta agonist, copromoted by Abbott's Ross Products Division, is currently approved as an inhalation solution...